Board to Provide Independent Consultation and Oversight for Cannabis Analytics Platform Cannvas Data
TORONTO , March 11, 2019 /CNW/ - Cannvas MedTech Inc. ("Cannvas" or the "Company") (MTEC.CN) (3CM.F) (CANVF), a leading digital cannabis education and analytics company, is pleased to announce the appointment of Dinesh Kandanchatha to its newly-formed AI, Technology and Data Advisory Board. Mr. Kandanchatha will act as lead and brings with him a wealth of knowledge and expertise in the technology sector as founder and former Chief Technology Officer of Patriot One Technologies (PAT.V) (PTOTF) (0PL.F), a concealed weapons detection system that promises a safer world.
"As a serial entrepreneur with a significant background in start-up and early-stage companies, Dinesh is a valuable addition to our team and a logical choice to lead our newly-formed AI, Technology and Data Advisory Board," said Shawn Moniz , Chief Executive Officer, Cannvas MedTech. "Dinesh is passionate about seeking out meaningful opportunities to improve patient outcomes through technology. Working with Cannvas is a unique chance to be part of the transformation coming around cannabis and health care while using data to strengthen the validity of consumer behaviours, purchasing patterns and industry trends."
Mr. Kandanchatha has over 20 years of experience in start-up and early-stage companies, having raised over $100M dollars translating into over $1B in shareholder value. He has overseen two IPOs, eight acquisitions and been part of many early stage companies. He is a founder and former President and CTO of Patriot One Technologies. Currently he is Chief Operating Officer of Macadamian Technologies one of the leading healthcare product consultancies in Canada . A seasoned investor and mentor, Mr. Kandanchatha holds both a bachelor's degree and MBA from the University of Ottawa , is a Top 40 under 40 winner, serves as a board member on multiple public and private organizations, and has been featured in the Canadian Business Journal's entrepreneur spotlight.
The newly-formed AI, Technology and Data Advisory Board will provide independent consultation and oversight for Cannvas Data, the Company's cannabis analytics platform providing AI-driven cannabis data and analytics to organizations looking to learn more about the audiences in the cannabis space. With the global legal cannabis market projected to reach a valuation of $27 billion dollars by 2020 and $146.5 billion by 2025, Cannvas Data is positioning itself as a leader in cannabis analytics delving deep into the consumer behaviours, purchasing patterns and industry trends shaping the global cannabis sector.
About Cannvas MedTech Inc.
Cannvas MedTech is a leading digital cannabis education and analytics company. We design and build patient-focused platforms enabling our partners to harness the power of data and gain deeper insights into consumer behaviour.
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company's Management's Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.
SOURCE Cannvas MedTech Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/March2019/11/c5583.html